News items Vici grant for Michiel Vermeulen

15 April 2021

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO). 

Reading the epitranscriptome

Michiel Vermeulen will use his grant to further study the epitranscriptome. Recently it became apparent that RNA modifications play an important role in regulating gene expression in health and disease. In this project, the underlying molecular mechanisms will be studied in great detail during blood cell differentiation. Furthermore, aberrant RNA modification patterns will also be studied in leukemia.

Vici is targeted at outstanding senior researchers who have successfully demonstrated the ability to develop their own innovative lines of research, and to act as coaches for young researchers.

More information NWO-Vici: link

Michiel Vermeulen works at the Faculty of Science of Radboud University and is part of the interfaculty research institute RIMLS. 

Related news items


LUMO Labs and Oost NL invest in Aiosyn Investment accelerates development of artificial intelligence platform to improve diagnostics

7 February 2022 Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor. read more

Dutch-Nordic Alliance for Precision Cancer Medicine launched

26 November 2021 The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands. read more

Large AI project receives over €95 million for ten years of public-private research

23 September 2021 The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs. read more

Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview

22 July 2021 Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map. read more

Next Generation cytogenetics is on its way Does Optical Genome Mapping turn cytogenetics upside down?

7 July 2021 Dutch-French research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. read more

Miljoenen voor kennis- en investeringsconsortium op het gebied van AI

14 April 2021 Een kennis- en investeringsconsortium met het Radboudumc heeft acht miljoen euro subsidie gekregen om innovatie op het gebied van Artificial Intelligence (AI) versneld naar de markt te brengen. read more